FMP

FMP

Enter

PSTV - Plus Therapeuti...

photo-url-https://financialmodelingprep.com/image-stock/PSTV.png

Plus Therapeutics, Inc.

PSTV

NASDAQ

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It has a license agreement with NanoTx, Corp. to develop and commercialize NanoTx's glioblastoma treatment. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.

1.41 USD

0.11 (7.8%)

About

ceo

Dr. Marc H. Hedrick M.B.A., M.D.

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It has a license agreement with NanoTx, Corp. to develop and commercialize NanoTx's glioblastoma treatment. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Au...

CIK

0001095981

ISIN

US72941H5090

CUSIP

72941H400

Address

4200 Marathon Boulevard

Phone

737 255 7194

Country

US

Employee

20

IPO Date

Jul 11, 2001

PSTV Financial Summary

CIK

0001095981

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

72941H400

ISIN

US72941H5090

Country

US

Price

1.41

Beta

0.67

Volume Avg.

71.65k

Market Cap

8.31M

Shares

-

52-Week

0.97-2.78

DCF

5.83

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.46

P/B

-

Website

https://www.plustherapeutics.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest PSTV News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep